“Two new reports commissioned by the Foundation examine key issues around Medicare prescription drug spending and the role of competition in achieving savings. The first report, authored by Jack Hoadley of Georgetown University, examines factors that contributed to Medicare’s lower-than-expected spending on prescription drugs under the Medicare Part D drug benefit begin in 2006. The second report authored by Richard G. Frank of Harvard University, considers areas where opportunities for market-based competition to drive down drug spending is limited.”

• Fact Sheet: The Medicare Prescription Drug Benefit
• Interactive: Medicare Health and Prescription Drug Plan Tracker